Underlying mechanisms of schistosome/snail compatibility

血吸虫/蜗牛相容性的潜在机制

基本信息

  • 批准号:
    7881838
  • 负责人:
  • 金额:
    $ 3.6万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2009
  • 资助国家:
    美国
  • 起止时间:
    2009-08-14 至 2010-07-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): This revised proposal seeks support for an investigator-initiated research project into the cellular and molecular means used by intermediate hosts of a human parasite to immunologically attack and kill these parasites. The broad, long-term objective is to break the cycle of parasite transmission to at-risk human populations. The research builds on recent progress in the applicant's laboratory and other laboratories, and exploits the principles of comparative functional genomics and an emerging database for the host snail's genome. In particular, the research deals with genes, messenger RNAs and proteins involved in the cellular respiratory burst - a complex pathway in which damaging reactive oxygen and nitrogen species are produced by the defense cells of the host and which are at least partialy responsible for the capacity of individual snails to resist infection. The aims address plausible hypotheses dealing with (i) genes: details of gene structure, transcription and post-transcriptional editing, (ii) proteins (including enzyme activities), (iii) activation pathways for cell responses, and (iv) ultimate causes of death of sporocysts. The hypotheses are both tractable and reasonably anchored in already demonstrated phenomena. Experimental materials include individual Biomphalaria glabrata snails with known susceptible or resistant phenotypes to a standard strain (Oregon PR1) of Schistosoma mansoni, a causative agent of human intestinal schistosomiasis. Funds will enable a team of researchers to focus their efforts on these issues over 5 years. Knowledge resulting from the studies is expected to enhance the likelihood of achieving a mission of this agency - prevention of future transmission of schistosome parasites (S. mansoni) to humans - accomplished by interruption of the parasite's life cycle in its intermediate host, B. glabrata. These goals will be addressed using inbred strains of the intermediate host snail species for which we have the necessary genetic information (nucleic acid sequence data) and in which it is now feasible to use sensitive reporters for and efficient inhibitors of a variety of cell functions. PUBLIC HEALTH RELEVANCE: The burden of this (human blood-fluke) parasite is considerable among human populations in endemic regions (>70 countries in which ~200,000,000 people are infected). Infected individuals experience lower levels of cognition (it is harder to learn), and of energy to do physical work. Hence this work, in which the ultimate aim is to break the cycle of schistosome transmission, may contribute to public welfare through enhancement of health and of the quality of life (improved capacities to learn and to do physical work).
描述(由申请人提供):本修订提案旨在支持一项由免疫学家发起的研究项目,该项目旨在研究人类寄生虫中间宿主用于免疫攻击和杀死这些寄生虫的细胞和分子手段。广泛的长期目标是打破寄生虫向高危人群传播的循环。该研究建立在申请人实验室和其他实验室的最新进展的基础上,并利用了比较功能基因组学的原理和宿主蜗牛基因组的新兴数据库。特别是,研究涉及细胞呼吸爆发的基因,信使RNA和蛋白质-一个复杂的途径,其中有害的活性氧和氮物质由宿主的防御细胞产生,并且至少部分负责个体蜗牛抵抗感染的能力。这些目标解决了以下可能的假设:(i)基因:基因结构,转录和转录后编辑的细节,(ii)蛋白质(包括酶活性),(iii)细胞反应的激活途径,以及(iv)孢子囊死亡的最终原因。这些假说既易于处理,又合理地扎根于已经证明的现象中。实验材料包括已知对曼氏血吸虫标准株(俄勒冈州PR 1)敏感或耐药的个体光滑双脐螺(Biomphalaria glabrata),曼氏血吸虫是人类肠道血吸虫病的病原体。资金将使一个研究小组能够在5年内集中精力研究这些问题。从这些研究中获得的知识有望提高实现该机构使命的可能性--预防寄生虫的未来传播(S。mansoni)传播给人类-通过中断寄生虫在其中间宿主B中的生命周期来实现。光滑的这些目标将使用中间宿主蜗牛物种的近交系来解决,我们有必要的遗传信息(核酸序列数据),并且现在可以使用敏感的报告和各种细胞功能的有效抑制剂。 公共卫生相关性:这种(人血吸虫)寄生虫的负担在流行地区的人群中相当大(超过70个国家,其中约有2亿人感染)。感染者的认知水平较低(学习更困难),体力劳动的能量也较低。因此,这项工作的最终目标是打破恶性传播的循环,通过提高健康和生活质量(提高学习和从事体力劳动的能力),可能有助于公共福利。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

CHRISTOPHER JEFFREY BAYNE其他文献

CHRISTOPHER JEFFREY BAYNE的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('CHRISTOPHER JEFFREY BAYNE', 18)}}的其他基金

Underlying mechanisms of schistosome/snail compatibility
血吸虫/蜗牛相容性的潜在机制
  • 批准号:
    6370996
  • 财政年份:
    2001
  • 资助金额:
    $ 3.6万
  • 项目类别:
MECHANISMS OF ENHANCEMENT OF INNATE IMMUNITY
增强先天免疫力的机制
  • 批准号:
    2767680
  • 财政年份:
    2000
  • 资助金额:
    $ 3.6万
  • 项目类别:
SMALL INSTRUMENTATION GRANT
小型仪器补助金
  • 批准号:
    3522947
  • 财政年份:
    1991
  • 资助金额:
    $ 3.6万
  • 项目类别:
BIOMEDICAL RESEARCH SUPPORT
生物医学研究支持
  • 批准号:
    3518201
  • 财政年份:
    1987
  • 资助金额:
    $ 3.6万
  • 项目类别:
SCHISTOSOME-SNAIL COMPATIBILITY: UNDERLYING MECHANISMS
血吸虫与蜗牛的相容性:潜在机制
  • 批准号:
    3566937
  • 财政年份:
    1981
  • 资助金额:
    $ 3.6万
  • 项目类别:
SCHISTOSOME-SNAIL COMPATIBILITY: UNDERLYING MECHANISMS
血吸虫与蜗牛的相容性:潜在机制
  • 批准号:
    3566210
  • 财政年份:
    1981
  • 资助金额:
    $ 3.6万
  • 项目类别:
SCHIOTOSOME-SNAIL COMPATIBILITY: UNDERLYING MECHANISMS
裂殖体与蜗牛的相容性:潜在机制
  • 批准号:
    3444511
  • 财政年份:
    1981
  • 资助金额:
    $ 3.6万
  • 项目类别:
Underlying mechanisms of schistosome/snail compatibility
血吸虫/蜗牛相容性的潜在机制
  • 批准号:
    6755900
  • 财政年份:
    1981
  • 资助金额:
    $ 3.6万
  • 项目类别:
Underlying mechanisms of schistosome/snail compatibility
血吸虫/蜗牛相容性的潜在机制
  • 批准号:
    6640134
  • 财政年份:
    1981
  • 资助金额:
    $ 3.6万
  • 项目类别:
Underlying mechanisms of schistosome/snail compatibility
血吸虫/蜗牛相容性的潜在机制
  • 批准号:
    6894046
  • 财政年份:
    1981
  • 资助金额:
    $ 3.6万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 3.6万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 3.6万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 3.6万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 3.6万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 3.6万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 3.6万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 3.6万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 3.6万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 3.6万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 3.6万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了